Special Issue "Diagnosis and Management of Cardiovascular Disease (CVD) during the COVID-19 Pandemic"
Deadline for manuscript submissions: 25 September 2021.
Interests: preventive cardiology; epidemiology; cardiovascular health; cardiovascular risk prediction; cardiovascular rehabilitation; rehabilitation medicine; atherosclerotic cardiovascular risk; body volume measurement; body composition; obesity; artificial intelligence
As we know, COVID-19 reached pandemic levels in March 2020, resulting in almost 60 million confirmed cases and over 1.41 million deaths as of November 25, 2020. This has not only pushed the capacities of public health services, but has also radically changed how medical care is provided, making it essential to reorganize and adapt health systems across various specialties in order to prioritize and individualize patient care as necessary.
Patients with pre-existing cardiovascular diseases and risk factors (such as obesity, hypertension, and diabetes) have increased severity and mortality during SARS-CoV-2 infection compared to these comorbidities individually. It is suggested that a combined effect of these comorbidities may play a key role, as these conditions share several standard features with infectious disorders, including a chronic pro-inflammatory state and the attenuation of the innate immune response, which may make individuals more susceptible to disease complications. For example, severe obesity (BMI≥35 kg/mt2), is one of the comorbidities most related to admissions (i.e., hospitalization or ICU) and fatalities; however, the pathophysiological mechanism explaining the associations between obesity and fatal and non-fatal outcomes in COVID patients are not fully understood.
Several demographic and clinical characteristics are significant predictors of hospitalization and severe outcomes. COVID-19 disproportionately affects the African American and Hispanic populations, who have high rates of comorbid conditions and obesity. Regarding gender, male sex (at age 60 years or older) has shown a trend toward a higher risk of fatal outcomes in COVID-19 patients. With effective novel therapeutics and vaccines on the horizon, the direct and indirect consequences of COVID-19 continue to strain the practice of cardiovascular medicine. Understanding the current and future impacts of the COVID-19 pandemic on public health, patient care, cardiovascular management, and outcomes for patients with and without underlying cardiovascular diseases and risk factors is of the utmost importance. In this Special Issue, we welcome a diverse array of submissions that will increase the knowledge on the topic.
Dr. Jose Medina-Inojosa
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- COVID-19 Pandemic
- Public Health
- Cardiovascular Disease
- Cardiovascular Risk Factors
- Cardiovascular Outcomes
- Cardiovascular Manangement